Big Pharma Giants Schering and Merck Take Heavy Criticism Over Vytorin Failure This week Merck executives are very grateful for the revenue predictions for their blockbuster HPV vaccine, GARDASIL. Profits are predicted to climb from $300 million to $4 billion over the next … [Read more...] about Vytorin — Another FDA Failure To Protect Public